Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

NRG Oncology/RTOG 0438: A Phase I Trial of Highly Conformal Radiation Therapy for Liver Metastases.

Dawson LA, Winter KA, Katz AW, Schell MC, Brierley J, Chen Y, Kopek N, Crane CH, Willett CG.

Pract Radiat Oncol. 2019 Feb 27. pii: S1879-8500(19)30067-0. doi: 10.1016/j.prro.2019.02.013. [Epub ahead of print]

PMID:
30825666
2.

Role of pelvic chemoradiation therapy in patients with initially metastatic anal canal cancer: A National Cancer Data Base review.

Abdelazim YA, Rushing CN, Palta M, Willett CG, Czito BG.

Cancer. 2019 Mar 2. doi: 10.1002/cncr.32017. [Epub ahead of print]

PMID:
30825391
3.

Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Benson AB 3rd, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Gurski L, Freedman-Cass DA.

J Natl Compr Canc Netw. 2018 Jul;16(7):874-901. doi: 10.6004/jnccn.2018.0061.

PMID:
30006429
4.

Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.

Benson AB 3rd, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Freedman-Cass DA.

J Natl Compr Canc Netw. 2018 Jul;16(7):852-871. doi: 10.6004/jnccn.2018.0060.

PMID:
30006428
5.

Association of Interim FDG-PET Imaging During Chemoradiation for Squamous Anal Canal Carcinoma With Recurrence.

Hong JC, Cui Y, Patel BN, Rushing CN, Faught AM, Eng JS, Higgins K, Yin FF, Das S, Czito BG, Willett CG, Palta M.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1046-1051. doi: 10.1016/j.ijrobp.2018.04.062. Epub 2018 May 4.

PMID:
29891206
6.

Management of Locoregional Rectal Cancer.

Willett CG.

J Natl Compr Canc Netw. 2018 May;16(5S):617-619. doi: 10.6004/jnccn.2018.0037.

PMID:
29784739
7.

John Foster Dulles, his medical history and its impact on Cold War politics.

Pappas TN, Willett CG.

J Med Biogr. 2018 Jan 1:967772018771432. doi: 10.1177/0967772018771432. [Epub ahead of print]

PMID:
29761726
8.

The role of external beam radiotherapy in the treatment of hepatocellular cancer.

Chino F, Stephens SJ, Choi SS, Marin D, Kim CY, Morse MA, Godfrey DJ, Czito BG, Willett CG, Palta M.

Cancer. 2018 Sep 1;124(17):3476-3489. doi: 10.1002/cncr.31334. Epub 2018 Apr 12. Review.

PMID:
29645076
9.

NCCN Guidelines Insights: Colon Cancer, Version 2.2018.

Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Garrido-Laguna I, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Freedman-Cass DA.

J Natl Compr Canc Netw. 2018 Apr;16(4):359-369. doi: 10.6004/jnccn.2018.0021.

PMID:
29632055
10.

Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance).

Fuchs CS, Niedzwiecki D, Mamon HJ, Tepper JE, Ye X, Swanson RS, Enzinger PC, Haller DG, Dragovich T, Alberts SR, Bjarnason GA, Willett CG, Gunderson LL, Goldberg RM, Venook AP, Ilson D, O'Reilly E, Ciombor K, Berg DJ, Meyerhardt J, Mayer RJ.

J Clin Oncol. 2017 Nov 10;35(32):3671-3677. doi: 10.1200/JCO.2017.74.2130. Epub 2017 Oct 4.

11.

Targeting CXCR4-dependent immunosuppressive Ly6Clow monocytes improves antiangiogenic therapy in colorectal cancer.

Jung K, Heishi T, Incio J, Huang Y, Beech EY, Pinter M, Ho WW, Kawaguchi K, Rahbari NN, Chung E, Kim JK, Clark JW, Willett CG, Yun SH, Luster AD, Padera TP, Jain RK, Fukumura D.

Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):10455-10460. doi: 10.1073/pnas.1710754114. Epub 2017 Sep 12.

12.

Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy.

Jung K, Heishi T, Khan OF, Kowalski PS, Incio J, Rahbari NN, Chung E, Clark JW, Willett CG, Luster AD, Yun SH, Langer R, Anderson DG, Padera TP, Jain RK, Fukumura D.

J Clin Invest. 2017 Aug 1;127(8):3039-3051. doi: 10.1172/JCI93182. Epub 2017 Jul 10.

13.

Total neoadjuvant therapy for rectal cancer: An emerging option.

Ludmir EB, Palta M, Willett CG, Czito BG.

Cancer. 2017 May 1;123(9):1497-1506. doi: 10.1002/cncr.30600. Epub 2017 Mar 10. Review.

14.

Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Benson AB 3rd, Venook AP, Cederquist L, Chan E, Chen YJ, Cooper HS, Deming D, Engstrom PF, Enzinger PC, Fichera A, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wu CS, Gregory KM, Freedman-Cass D.

J Natl Compr Canc Netw. 2017 Mar;15(3):370-398.

PMID:
28275037
15.

Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.

Mowery YM, Salama JK, Zafar SY, Moore HG, Willett CG, Czito BG, Hopkins MB, Palta M.

Cancer. 2017 Apr 15;123(8):1434-1441. doi: 10.1002/cncr.30461. Epub 2016 Dec 16.

16.

A current perspective on stereotactic body radiation therapy for pancreatic cancer.

Hong JC, Czito BG, Willett CG, Palta M.

Onco Targets Ther. 2016 Oct 31;9:6733-6739. eCollection 2016. Review.

17.

Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation.

Swisher SG, Moughan J, Komaki RU, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CG.

J Thorac Oncol. 2017 Feb;12(2):368-374. doi: 10.1016/j.jtho.2016.10.002. Epub 2016 Oct 8.

18.

Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.

Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, Denlinger CS, Fanta P, Farjah F, Fuchs CS, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Korn WM, Leong S, Linn C, Lockhart AC, Ly QP, Mulcahy MF, Orringer MB, Perry KA, Poultsides GA, Scott WJ, Strong VE, Washington MK, Weksler B, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H.

J Natl Compr Canc Netw. 2016 Oct;14(10):1286-1312.

PMID:
27697982
19.

Nonoperative management of rectal cancer.

Torok JA, Palta M, Willett CG, Czito BG.

Cancer. 2016 Jan 1;122(1):34-41. doi: 10.1002/cncr.29735. Epub 2015 Nov 24. Review.

20.

Role of Adjuvant Radiotherapy in Locally Advanced Colonic Carcinoma in the Modern Chemotherapy Era.

Ludmir EB, Arya R, Wu Y, Palta M, Willett CG, Czito BG.

Ann Surg Oncol. 2016 Mar;23(3):856-62. doi: 10.1245/s10434-015-4907-3. Epub 2015 Oct 19.

PMID:
26480849
21.

Reflections from a chair: Leadership of a clinical department at an academic medical center.

Willett CG.

Cancer. 2015 Nov 1;121(21):3795-8. doi: 10.1002/cncr.29588. Epub 2015 Jul 28.

22.

Rectal Cancer, Version 2.2015.

Benson AB 3rd, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ, Fuchs CS, Grem JL, Grothey A, Hochster HS, Hunt S, Kamel A, Kirilcuk N, Leong LA, Lin E, Messersmith WA, Mulcahy MF, Murphy JD, Nurkin S, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Gregory KM, Freedman-Cass D.

J Natl Compr Canc Netw. 2015 Jun;13(6):719-28; quiz 728.

PMID:
26085388
23.

Investigation of the Lack of Angiogenesis in the Formation of Lymph Node Metastases.

Jeong HS, Jones D, Liao S, Wattson DA, Cui CH, Duda DG, Willett CG, Jain RK, Padera TP.

J Natl Cancer Inst. 2015 Jun 10;107(9). pii: djv155. doi: 10.1093/jnci/djv155. Print 2015 Sep.

24.

Human papillomavirus tumor infection in esophageal squamous cell carcinoma.

Ludmir EB, Stephens SJ, Palta M, Willett CG, Czito BG.

J Gastrointest Oncol. 2015 Jun;6(3):287-95. doi: 10.3978/j.issn.2078-6891.2015.001. Review.

25.

Esophageal and esophagogastric junction cancers, version 1.2015.

Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Besh S, Chao J, Das P, Denlinger C, Fanta P, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Jasperson K, Keswani RN, Kleinberg LR, Korn WM, Leong S, Lockhart AC, Mulcahy MF, Orringer MB, Posey JA, Poultsides GA, Sasson AR, Scott WJ, Strong VE, Varghese TK Jr, Washington MK, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H; National comprehensive cancer network.

J Natl Compr Canc Netw. 2015 Feb;13(2):194-227.

PMID:
25691612
26.

Is proton beam therapy better than standard radiation therapy? A paucity of practicality puts photons ahead of protons.

Salama JK, Willett CG.

Clin Adv Hematol Oncol. 2014 Dec;12(12):861, 865-6, 869. No abstract available.

PMID:
25674847
27.

Efficacy endpoints of radiation therapy group protocol 0247: a randomized, phase 2 study of neoadjuvant radiation therapy plus concurrent capecitabine and irinotecan or capecitabine and oxaliplatin for patients with locally advanced rectal cancer.

Wong SJ, Moughan J, Meropol NJ, Anne PR, Kachnic LA, Rashid A, Watson JC, Mitchell EP, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG.

Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):116-23. doi: 10.1016/j.ijrobp.2014.09.031. Epub 2014 Nov 5.

28.

Patterns of failure for stage I ampulla of Vater adenocarcinoma: a single institutional experience.

Zhong J, Palta M, Willett CG, McCall SJ, McSherry F, Tyler DS, Uronis HE, Czito BG.

J Gastrointest Oncol. 2014 Dec;5(6):421-7. doi: 10.3978/j.issn.2078-6891.2014.084.

29.

Incidence and prognostic impact of high-risk HPV tumor infection in cervical esophageal carcinoma.

Ludmir EB, Palta M, Zhang X, Wu Y, Willett CG, Czito BG.

J Gastrointest Oncol. 2014 Dec;5(6):401-7. doi: 10.3978/j.issn.2078-6891.2014.053.

30.

A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors.

Hong TS, DeLaney TF, Mamon HJ, Willett CG, Yeap BY, Niemierko A, Wolfgang JA, Lu HM, Adams J, Weyman EA, Arellano RS, Blaszkowsky LS, Allen JN, Tanabe KK, Ryan DP, Zhu AX.

Pract Radiat Oncol. 2014 Sep-Oct;4(5):316-322. doi: 10.1016/j.prro.2013.10.002. Epub 2013 Nov 22.

31.

Colon cancer, version 3.2014.

Benson AB 3rd, Venook AP, Bekaii-Saab T, Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, Messersmith W, Mulcahy MF, Murphy JD, Nurkin S, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Gregory KM, Freedman-Cass DA; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 Jul;12(7):1028-59.

PMID:
24994923
32.

Results of the FFCD 9901 trial in early-stage esophageal carcinoma: is it really about neoadjuvant therapy?

Czito BG, Palta M, Willett CG.

J Clin Oncol. 2014 Aug 10;32(23):2398-400. doi: 10.1200/JCO.2014.55.7231. Epub 2014 Jun 30. No abstract available.

PMID:
24982460
33.

Short-course versus long-course chemoradiation in rectal cancer--time to change strategies?

Palta M, Willett CG, Czito BG.

Curr Treat Options Oncol. 2014 Sep;15(3):421-8. doi: 10.1007/s11864-014-0296-2. Review.

PMID:
24915746
34.

Patterns of recurrence after trimodality therapy for esophageal cancer.

Dorth JA, Pura JA, Palta M, Willett CG, Uronis HE, D'Amico TA, Czito BG.

Cancer. 2014 Jul 15;120(14):2099-105. doi: 10.1002/cncr.28703. Epub 2014 Apr 7.

35.

Colorectal cancer: adjuvant chemotherapy for rectal cancer-an unresolved issue.

Palta M, Czito BG, Willett CG.

Nat Rev Clin Oncol. 2014 Apr;11(4):182-4. doi: 10.1038/nrclinonc.2014.43. Epub 2014 Mar 18. No abstract available.

PMID:
24642673
36.

Oncology scan--gastrointestinal cancers.

Willett CG, Chang D, Czito B, Meyer J, Wo J.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):861-3. doi: 10.1016/j.ijrobp.2013.09.006. No abstract available.

PMID:
24267962
37.

Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial.

Gunderson LL, Moughan J, Ajani JA, Pedersen JE, Winter KA, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett CG.

Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):638-45. doi: 10.1016/j.ijrobp.2013.07.035. Epub 2013 Sep 10.

38.

Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010.

Cai S, Hong TS, Goldberg SI, Fernandez-del Castillo C, Thayer SP, Ferrone CR, Ryan DP, Blaszkowsky LS, Kwak EL, Willett CG, Lillemoe KD, Warshaw AL, Wo JY.

Cancer. 2013 Dec 1;119(23):4196-204. doi: 10.1002/cncr.28329. Epub 2013 Sep 4.

39.

Inhibiting the inhibitor: targeting vascular endothelial protein tyrosine phosphatase to promote tumor vascular maturation.

Kontos CD, Willett CG.

J Natl Cancer Inst. 2013 Aug 21;105(16):1163-5. doi: 10.1093/jnci/djt199. Epub 2013 Jul 30. No abstract available.

PMID:
23899554
40.

Multidisciplinary management of locally advanced rectal cancer: neoadjuvant approaches.

Murugappan S, Harris WP, Willett CG, Lin E.

J Natl Compr Canc Netw. 2013 May 1;11(5):548-57. Review.

PMID:
23667205
41.

Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines.

Benson AB 3rd, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W Jr, Sofocleous CT, Venook AP, Willett CG, Gregory KM, Freedman-Cass DA; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 May 1;11(5):519-28.

PMID:
23667203
42.

Practical radiation oncology for surgeons.

Willett CG.

Surg Oncol Clin N Am. 2013 Jul;22(3):xv-xvi. doi: 10.1016/j.soc.2013.02.013. Epub 2013 Feb 26. No abstract available.

PMID:
23622084
43.

Implementing and integrating a clinically driven electronic medical record for radiation oncology in a large medical enterprise.

Kirkpatrick JP, Light KL, Walker RM, Georgas DL, Antoine PA, Clough RW, Cozart HB, Yin FF, Yoo S, Willett CG.

Front Oncol. 2013 Apr 18;3:69. doi: 10.3389/fonc.2013.00069. eCollection 2013.

44.

ACT II: treatment of anal cancer comes full circle.

Willett CG, Czito BG, Palta M.

Lancet Oncol. 2013 May;14(6):443-5. doi: 10.1016/S1470-2045(13)70121-9. Epub 2013 Apr 9. No abstract available.

PMID:
23578723
45.

The role of local excision in invasive adenocarcinoma of the ampulla of Vater.

Zhong J, Palta M, Willett CG, McCall SJ, Bulusu A, Tyler DS, White RR, Uronis HE, Pappas TN, Czito BG.

J Gastrointest Oncol. 2013 Mar;4(1):8-13. doi: 10.3978/j.issn.2078-6891.2012.055.

46.

Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.

Benson AB 3rd, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fenton MJ, Fuchs CS, Grem JL, Hunt S, Kamel A, Leong LA, Lin E, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W Jr, Sofocleous CT, Venook AP, Willett CG, Gregory KM, Freedman-Cass DA.

J Natl Compr Canc Netw. 2013 Feb 1;11(2):141-52; quiz 152.

PMID:
23411381
47.

Preoperative chemoradiotherapy for locally advanced gastric cancer.

Pepek JM, Chino JP, Willett CG, Palta M, Blazer Iii DG, Tyler DS, Uronis HE, Czito BG.

Radiat Oncol. 2013 Jan 4;8:6. doi: 10.1186/1748-717X-8-6.

48.

Rectal cancer.

Benson AB 3rd, Bekaii-Saab T, Chan E, Chen YJ, Choti MA, Cooper HS, Engstrom PF, Enzinger PC, Fakih MG, Fuchs CS, Grem JL, Hunt S, Leong LA, Lin E, Martin MG, May KS, Mulcahy MF, Murphy K, Rohren E, Ryan DP, Saltz L, Sharma S, Shibata D, Skibber JM, Small W Jr, Sofocleous CT, Venook AP, Willett CG, Freedman-Cass DA, Gregory KM.

J Natl Compr Canc Netw. 2012 Dec 1;10(12):1528-64.

PMID:
23221790
49.

Technical considerations in radiation therapy for gastroesophageal junction cancer.

Pepek JM, Willett CG, Czito BG.

Semin Radiat Oncol. 2013 Jan;23(1):51-9. doi: 10.1016/j.semradonc.2012.09.005. Review.

PMID:
23207047
50.

RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal.

Kachnic LA, Winter K, Myerson RJ, Goodyear MD, Willins J, Esthappan J, Haddock MG, Rotman M, Parikh PJ, Safran H, Willett CG.

Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):27-33. doi: 10.1016/j.ijrobp.2012.09.023. Epub 2012 Nov 12.

Supplemental Content

Loading ...
Support Center